BioSerenity, developer of solutions dedicated to personalized patient continuous care, raises €65 million, including €50 million in Series B equity financing led by Dassault Systèmes …
Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity
Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity
Leave a reply